Vimarsana
Biggest News Aggregation in the World

Ltd Otsuka News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Ltd Otsuka. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Ltd Otsuka Today - Breaking & Trending Today

Akebia Therapeutics Reports First Quarter 2022 Financial Results and Business Update - Vimarsana News

Akebia Therapeutics Reports First Quarter 2022 Financial Results and Business Update

Published: May 9, 2022

/PRNewswire/ -- Akebia Therapeutics®, Inc. (Nasdaq: AKBA), a biopharmaceutical company with the purpose to better the lives of people impacted by kidney...

Source: prnewswire.com
Related Topics:
United KingdomUnited StatesDavida SpellmanMercedes CarrascoJohn ButlerLtd OtsukaDrug AdministrationAkebia Therapeutics IncExchange CommissionUs Food Drug AdministrationOtsuka Pharmaceuticals CoEuropean Medicines AgencyComplete Response LetterChief Executive OfficerNew Drug ApplicationOtsuka PharmaceuticalsChief Financial OfficerChildren DueAccidental IngestionDeficiency AnemiaAkebia TherapeuticsSecurities Litigation Reform ActAnnual Report
Akebia Therapeutics Reports Fourth Quarter and Full-Year 2021 Financial Results and Recent Business Highlights - Vimarsana News

Akebia Therapeutics Reports Fourth Quarter and Full-Year 2021 Financial Results and Recent Business Highlights

Published: March 1, 2022

/PRNewswire/ -- Akebia Therapeutics®, Inc. (Nasdaq: AKBA), a biopharmaceutical company with the purpose to better the lives of people impacted by kidney...

Source: prnewswire.com
Related Topics:
United KingdomUnited StatesVifor PharmaDell FaulkinghamMercedes CarrascoJohnp ButlerVifor Pharma GroupLtd OtsukaDrug AdministrationAkebia Therapeutics IncExchange CommissionJapan Ministry Of HealthEuropean Medicines AgencyOtsuka Pharmaceuticals CoPrescription Drug User Fee ActChief Executive OfficerChief Commercial OfficerTransitional Drug Add On Payment AdjustmentOtsuka PharmaceuticalsPriority Review VoucherAkebia TherapeuticsNew Drug ApplicationMarketing Authorization ApplicationChronic Kidney DiseaseChildren Due